Researchers have found a novel strategy for engrafting engineered cells into injured lung tissue. These findings might result in new methods for treating lung ailments, reminiscent of emphysema, pulmonary fibrosis and COVID-19. The 2 research describe the methodologies for engineering lung stem cells and transplanting them into injured experimental lungs with out immunosuppression.